NCT00969839

NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures

A Study to Evaluate the Safety and Effectiveness of the NovaLign Intramedullary Fixation System for the Treatment of Humeral Diaphysis Fractures

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: NovaLign Orthopaedics, Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.

Detailed description

This is an observational, prospective, nonrandomized open label, post-market clinical study, designed to evaluate the use a flexible intramedullary fixation device used in the treatment of fractures of the humerus. This is a multicentre trial.

Conditions

• Fracture

Interventions

Type	Name	Description
DEVICE	NovaLign Intramedullary Fixation System	Intramedullary fixation of broken humerus

Timeline

• Start date: 2009-09-01
• Primary completion: 2011-03-01
• Completion: 2011-03-01
• First posted: 2009-09-01
• Last updated: 2009-09-18

Locations

2 sites across 1 country: United States